INDEX VALUES   |

Home > Our Indexes > LSCIBP

Download Methodology

LifeSci Biotechnology Products Index


LifeSci Biotechnology Products Index ("LSCIBP") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval. The inception date for LSCIBP was November 3, 2014.

LSCIBPS&P 500
Prior Day Closing Value7318.864771.02
Prior Day Change %+0.11%-0.59%
Current Value
Current Day Change %-0.80%+1.51%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Nov 20, 2017)


No. of Constituents 36
Total Market Cap ($ in millions) 0
Mean Market Cap ($ in millions) 0
Median Market Cap ($ in millions) 0
Largest Constituent ($ in millions) 0
Smallest Constituent ($ in millions) 0

Market Cap Breakdown (Nov 20, 2017)


Top 10 Constituents (Nov 20, 2017)


Constituent Ticker Weight
Nektar Therapeutics NKTR 6.80%
Sarepta Therapeutics Inc SRPT 4.59%
Neurocrine Biosciences Inc NBIX 4.41%
Enanta Pharmaceuticals Inc ENTA 4.18%
Halozyme Therapeutics Inc HALO 3.83%
Exelixis Inc EXEL 3.52%
Biogen Inc BIIB 3.30%
Vertex Pharmaceuticals Inc VRTX 3.13%
Retrophin Inc RTRX 3.10%
Acorda Therapeutics Inc ACOR 3.06%
Data Updated Daily
Download All Constituents